 |
Yeast Traffic Light PNA FISH test receives FDA 510(k) clearance
|
|
AdvanDx receives FDA 510(k) clearance for a fast, 90 minutes protocol for its Yeast Traffic Light PNA FISH test. |
|
|
Myconostica receives CE Mark for MycAssay platforms
|
|
UK-based medical diagnostic company, Myconostica, receives the CE marking of its lead products MycAssay Aspergillus and MycAssay Pneumocystis on the Roche Lightcycler 2.0 and Stratagene Mx3000 series platforms. |
|
|
Queen Elizabeth Hospital, Gateshead laboratory applies Lean technology
|
|
The Pathology Department at the Queen Elizabeth Hospital, Gateshead, which runs a high throughput blood science laboratory, is aiming to increase efficiency and reduce waste through the application of Lean principles. |
|
|
Cyprotex unveils new in vitro toxicology service in Macclesfield, UK
|
|
Cyprotex launches the company’s new in vitro toxicology service, branded as Cyprotox and will be supporting the new service with an additional 90 square metres of laboratory space at Cyprotex's Macclesfield, UK facility. |
|
|
The Yorkshire Clinic upgrades immunoassay system for tumour marker testing
|
|
The Yorkshire Clinic, part of the Ramsay Health Care group, is upgrading its immunoassay system to a Siemens Healthcare Diagnostics’ IMMULITE 2000 XPi. |
|
|
Next-generation UV-Visible spectrophotometers offer enhanced productivity.
|
|
Thermo Fisher Scientific launches its Evolution 200 series of next-generation UV-Visible spectrophotometers featuring new INSIGHT software with CUE (Customized User Environment) scripting capabilities. |
|
|
Qiagen flexible automated solution sets new standards for molecular testing
|
|
Qiagen is launching its flexible automated solution QIAsymphony RGQ which is a novel, integrated system that claims to set new standards for molecular testing and incorporates all workflow steps from sample to detection. |
|
|
Myconostica receives the CE mark MycAssay Aspergillus solution
|
|
Myconostica receives the CE mark for the company’s lead product, MycAssay Aspergillus for detection of Aspergillus DNA in serum. |
|
|
Myconostica presents positive data from study of MycAssay Pneumocystis
|
|
Myconostica is presenting positive data from a multi-centre prospective evaluation of MycAssay Pneumocystis, the company's CE marked diagnostic product for detection of Pneumocystis DNA in respiratory samples. |
|
|
New kit quickly identifies microorganisms from positive blood culture bottles
|
|
Bruker Daltonics is introducing the new MALDI Sepsityper kit for the rapid identification of microorganisms from positive blood culture bottles, using Bruker’s industry-leading MALDI Biotyper solution. |
|
|
Roche Diagnostics unveils STAT immunoassays for cardiac biomarker testing
|
|
Roche Diagnostics is introducing a complete battery of STAT immunoassays for cardiac biomarker testing on the cobas 6000 analyser series, an integrated system designed for diagnostic labs with medium testing volumes. |
|
|
Quintet of mass spectrometry software solutions boost proteomics research
|
|
Thermo Fisher Scientific unveils a suite of five complementary software solutions and enhancements designed to achieve breakthrough progress in qualitative and quantitative proteomics. |
|
|
Caliper Life Sciences unveils safety pharmacology profiling service
|
|
Caliper Life Sciences introduces its General Side Effects Profile (GENSEP), a service offering through its Caliper Discovery Alliances and Services (CDAS) unit, to assess the potential for safety liabilities of drugs under Good Laboratory Practices (GLP). |
|
|
Alere launches diagnostic test to identify heart failure
|
|
Alere International launches the company’s new Triage NT-proBNP test, which when used in conjunction with clinical assessment, the NT-proBNP (N-terminal pro b-type natriuretic peptide) test is a useful biomarker in the diagnosis and management of patients with heart failure. |
|
|
Online technical poster demonstrates benefits of biobanks
|
|
Thermo Fisher Scientific is offering a new technical poster demonstrating its comprehensive portfolio of offerings for biobanks and biorepositories. |
|
|
Quidel receives 510(k) clearance for immunoassay test of RSV infections
|
|
Quidel receives 510(k) clearance from the United States Food and Drug Administration (FDA) for the sale of the company’s QuickVue RSV 10, a lateral flow immunoassay test for the qualitative detection of acute respiratory syncytial virus (RSV) infections. |
|
|
ETH Zurich generates world’s first human Multiple Reaction Monitoring Atlas
|
|
Scientists at the Swiss Federal Institute of Technology (ETH Zurich), in collaboration with the Institute for Systems Biology in Seattle, Washington, USA, used next-generation QTRAP mass spectrometry technology from AB SCIEX to create assays for approximately 20,000 human proteins, generating the wo |
|
|
Qiagen and Abbott agree molecular tests for HIV, HCV and HPV
|
|
Qiagen and Abbott are entering into an agreement that strengthens both companies' testing menus for automated in-vitro diagnostic applications in the United States and Canada. |
|
|
Syprosoft completes innovative diabetes monitoring test
|
|
Syprosoft Engineering completes development of a prototype for The G1A Rapid Diabetes Monitoring Index Reader, an innovative diabetes monitoring test. |
|
|
Free evaluation kit focuses on Tina-quant a HbA1c Generation 2 assay
|
|
Roche is offering a free evaluation kit for the Tina-quant [a] HbA1c Generation 2 assay – an efficient, accurate, cost effective hbA1c testing solution that is easily consolidated onto several Roche platforms. |
|
|
London Metropolitan University selects Jenway spectrophotometers for Super Lab
|
|
London Metropolitan University’s Faculty of Life Sciences claims to be the biggest wet teaching lab in Europe which features 280 individual workstations and an extensive range of state-of-the-art equipment, including 16 Jenway 7315 spectrophotometers supplied by Bibby Scientific. |
|
|
Managed laboratory service contract offers cost benefits to Cwm Taf NHS Trust
|
|
In the quest to improve services for patients while saving cost Cwm Taf NHS Trust turns to Roche Diagnostics which secured the first managed laboratory service contract awarded in Wales following a competitive procurement process. |
|
|
New assay-ready, on-demand chemical supply service is launched
|
|
Molplex is partnering Peakdale Molecular to launch a pioneering new assay-ready, on-demand chemical supply service. |
|
|
PCR-based EGFR assay receives SFDA approval in China
|
|
China Medical Technologies receives approval for its real-time PCR-based Epidermal Growth Factor Receptor (EGFR) Assay for the use of lung cancer targeted drugs from the State Food and Drug Administration of China. |
|
|
Roche Diagnostics partners CapitalBio to develop molecular diagnostic solutions
|
|
Roche Diagnostics and CapitalBio plan to initiate a strategic partnership targeting molecular diagnostic applications and the development of technologies to fill the unmet needs of researchers worldwide. |
|
|
Astra Biotech showcases assays for allergies and hormonal dysfunctions
|
|
Berlin-based Astra Biotech is a new company whose core focus is the development of innovative diagnostics for the identification of an individual’s predisposition to disease and will be showcasing at Medica 2010 in Dusseldorf, Germany (Hall 03/G54) the company’s current portfolio of assa |
|
|
Alere launches world’s first fingerstick BNP test
|
|
Alere launches the world’s first fingerstick BNP (b-type natriuretic peptide) test as an aid in diagnosis and assessment of severity of patients with heart failure. |
|
|
Astra Biotech invites trial evaluations of its range of diagnostic assays
|
|
Astra Biotech is inviting new customers to evaluate its range of diagnostic assays as a test of their quality and value for money. |
|
|
Biomoda selects Quintiles to develop detector for early-stage lung cancer
|
|
Biomoda is collaborating with Quintiles Global Central Laboratories to help refine the automated image recognition system for measuring the photon emission rate and cell morphology of CyPath-stained cells to detect early stage lung cancer. |
|
|
Osteoporosis diagnostic test kit finds polymorphisms in COLIA1 and VDR genes
|
|
Astra Biotech is offering a new Osteoporosis Kit diagnostic test kit using RT-PCR for the detection of polymorphisms in the COLIA1 and VDR genes to improve the identification of defects which result in abnormalities in bone matrix mineralization. |
|
|
Luminex's first pharmacogenetic test to support personalized medicine
|
|
Luminex launches its first pharmacogenetic test, the xTAG CYP2D6 Kit, which has received 510(k) clearance from the US Food and Drug Administration (FDA). |
|
|
Covaris works with Tecan to promote non-contact sample preparation technology
|
|
Covaris, a company providing advanced sample preparation solutions for life and analytical science, is collaborating with Tecan to co-promote the Freedom EVO liquid handling platform with integrated Adaptive Focused Acoustics (AFA). |
|
|
Automated microplate washer helps clean sensitive immunoassay
|
|
Tecan’s HydroFlex microplate washer is allowing haematologists at the Department of Oncology and Hematology, University of Modena and Reggio Emilia, Italy, to introduce automated washing for Enzyme-Linked ImmunoSpot (ELISpot) assays. |
|
|
Study shows test improves diagnosis of Aspergillus bronchitis in CF patients
|
|
At the annual British Thoracic Society meeting in London Dr Caroline Baxter reports the sensitive performance of Myconostica's real-time PCR assay MycAssay Aspergillus in cystic fibrosis (CF) sputum(Ref 1) which is 260 percent more sensitive than the currently used culture. |
|
|
Point-of-care immunoassay analyser focuses on critical biomarkers
|
|
Global provider of point-of-care blood gas analysers, Radiometer is using the company’s expertise in acute clinical testing to develop a compact and cost-effective immunoassay analyser for measuring critical biomarkers at the patient’s bedside. |
|
|
One Lambda renews strategic HLA partnership with Luminex
|
|
One Lambda and Luminex agree to a long-term renewal of their 10-year strategic partnership aimed at developing platforms and technologies for human leukocyte antigen (HLA). |
|
|
Cellular analysis system offers controlled shear flow solution
|
|
Fluxion Biosciences is launching the company’s new BioFlux 1000Z system for live cell imaging at the 50th American Society for Cell Biology Annual Meeting to be held December 11-15, 2010 in Philadelphia, Pennsylvania, USA. |
|
|
Caliper continues support for US EPA's expanded ToxCast programme
|
|
Caliper Life Sciences is receiving the remaining balance of the compound library for the Environmental Protection Agency's (EPA) Phase II ToxCast screening programme. |
|
|
Gas control module extends the experimental window of microplate investigations
|
|
Tecan launches a Gas Control Module (GCM) for its Infinite 200 PRO multimode microplate reader, to create one of the most comprehensive solutions on the market for cell-based assays. |
|
|
BioSystem Development signs collaboration deal with Agilent Technologies
|
|
BioSystem Development and Agilent Technologies signs a collaborative agreement to implement BioSystem Development’s patented technology on the established Agilent Bravo automated liquid handling platform. |
|
|
Compendia Bioscience partners Althea Diagnostics to analyse assay data
|
|
Compendia Bioscience is forming a new strategic partnership with Althea Diagnostics and the immediate availability of the partnership's first joint product and service offerings - the Breast Cancer Segregation Panel Assay and Analysis Service. |
|
|
Study shows benefits of therapeutic filtration devices for colorectal cancer treament
|
|
Aethlon Medical, the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, is demonstrating the ability to capture immunosuppressive exosomes derived from individuals with lymphoma and colorectal cancer. |
|
|
Clinical study assesses novel point-of-care blood biomarker test for NGAL
|
|
The Alere Triage NGAL test is a point-of-care fluorescence immunoassay to be used with the Alere Triage Meter Pro for the rapid, quantitative determination of NGAL in EDTA anti-coagulated whole blood or plasma specimens. |
|
|
BD Diagnostics files for 510(k) clearance of HSV-1 and HSV-2 molecular tests
|
|
BD Diagnostics, a segment of BD (Becton, Dickinson and Company) is filing for US Food and Drug Administration (FDA) 510(k) clearance for the first fully automated molecular tests to diagnose and differentiate Herpes Simplex Viruses types 1 and 2. |
|
|
BG Medicine partners Siemens Healthcare Diagnostics to develop galectin-3 test
|
|
BG Medicine enters into an agreement with Siemens Healthcare Diagnostics, a division of Siemens Healthcare, for the development and commercialization of a galectin-3 test for Siemens’ automated immunoassay platforms for clinical laboratories. |
|
|
Critical Diagnostics begins European commercialization of Presage ST2 Assay
|
|
Critical Diagnostics receives CE Mark for its high sensitivity Presage ST2 Assay and is commencing commercialization in Europe. |
|
|
Biotage releases new series of solid phase extraction application notes
|
|
Biotage introduces a new series of application notes utilizing the industry-standard RapidTrace SPE Workstation. |
|
|
Clinical assay for Procalcitonin showcases at Critical Care Conference 2011
|
|
Thermo Fisher Scientific plans to showcase its clinical assay for Procalcitonin (PCT), which aids in the risk assessment of critically ill patients with sepsis, at the Society of Critical Care Medicine (SCCM) 40th Critical Care Conference 2011. |
|
|
Illumina unveils next generation of custom genotyping solutions
|
|
Illumina is introducing its next generation of iSelect custom genotyping products to allow researchers to design custom arrays containing from 3,000 up to 1,000,000 markers, with the flexibility to add supplemental content to their array designs. |
|
|
Italian hospital plans early stage neonatal diagnostic test for Tyrosinemia Type I
|
|
PerkinElmer and the Meyer Children’s Hospital of Florence, a leading Italian research centre are collaborating to develop an early stage neonatal diagnostic test for Tyrosinemia Type I, a rare metabolic genetic disease that is lethal if untreated, but curable if detected early. |
|
